Medplus Health Services Limited

69%

s 27k+ Employees Serving the Customers of ~750 Cities Store level Unit economics with ROCE of ~69% Q2FY26 2 ~1,068 Outlets which are < 24M, upon maturity are P&L accretive Q2 FY2026 Highlights

₹ 16,793

are < 24M, upon maturity are P&L accretive Q2 FY2026 Highlights (1/2) e t a d p U s t l u s e R ₹ 16,793m Revenue • ₹ 1,032m increase over Q2FY25 6.5% ₹ 4,391m Gross Margin • 26.1% GM%, increased by 240

₹ 1,032

rity are P&L accretive Q2 FY2026 Highlights (1/2) e t a d p U s t l u s e R ₹ 16,793m Revenue • ₹ 1,032m increase over Q2FY25 6.5% ₹ 4,391m Gross Margin • 26.1% GM%, increased by 240 bps yoy yoy •

6.5%

2026 Highlights (1/2) e t a d p U s t l u s e R ₹ 16,793m Revenue • ₹ 1,032m increase over Q2FY25 6.5% ₹ 4,391m Gross Margin • 26.1% GM%, increased by 240 bps yoy yoy • ₹ 1,367m increase over Q1FY

₹ 4,391

ghlights (1/2) e t a d p U s t l u s e R ₹ 16,793m Revenue • ₹ 1,032m increase over Q2FY25 6.5% ₹ 4,391m Gross Margin • 26.1% GM%, increased by 240 bps yoy yoy • ₹ 1,367m increase over Q1FY26 8.9%

26.1%

p U s t l u s e R ₹ 16,793m Revenue • ₹ 1,032m increase over Q2FY25 6.5% ₹ 4,391m Gross Margin • 26.1% GM%, increased by 240 bps yoy yoy • ₹ 1,367m increase over Q1FY26 8.9% qoq • 3.3% increase i

240 bps

793m Revenue • ₹ 1,032m increase over Q2FY25 6.5% ₹ 4,391m Gross Margin • 26.1% GM%, increased by 240 bps yoy yoy • ₹ 1,367m increase over Q1FY26 8.9% qoq • 3.3% increase in private label over Q2F

₹ 1,367

m increase over Q2FY25 6.5% ₹ 4,391m Gross Margin • 26.1% GM%, increased by 240 bps yoy yoy • ₹ 1,367m increase over Q1FY26 8.9% qoq • 3.3% increase in private label over Q2FY25 117 Store Net Add

8.9%

4,391m Gross Margin • 26.1% GM%, increased by 240 bps yoy yoy • ₹ 1,367m increase over Q1FY26 8.9% qoq • 3.3% increase in private label over Q2FY25 117 Store Net Additions • 145 gross additions

3.3%

Margin • 26.1% GM%, increased by 240 bps yoy yoy • ₹ 1,367m increase over Q1FY26 8.9% qoq • 3.3% increase in private label over Q2FY25 117 Store Net Additions • 145 gross additions • 68 net add

2.2%

s additions • 68 net additions beyond Tier-One • 4,930 stores as on 30-Sep-25 Stores > 12 months • 2.2% revenue growth over Q2FY25 • 11.8% Store Level EBITDA margin • 68.6% Store Level Operating ROCE ₹

11.8%

ond Tier-One • 4,930 stores as on 30-Sep-25 Stores > 12 months • 2.2% revenue growth over Q2FY25 • 11.8% Store Level EBITDA margin • 68.6% Store Level Operating ROCE ₹ 839m Pharmacy Operating EBITDA •